<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39402206</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>14</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2731-0590</ISSN><JournalIssue CitedMedium="Internet"><Volume>3</Volume><Issue>10</Issue><PubDate><Year>2024</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Nature cardiovascular research</Title><ISOAbbreviation>Nat Cardiovasc Res</ISOAbbreviation></Journal><ArticleTitle>CCL2-mediated endothelial injury drives cardiac dysfunction in long COVID.</ArticleTitle><Pagination><StartPage>1249</StartPage><EndPage>1265</EndPage><MedlinePgn>1249-1265</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s44161-024-00543-8</ELocationID><Abstract><AbstractText>Evidence linking the endothelium to cardiac injury in long coronavirus disease (COVID) is well documented, but the underlying mechanisms remain unknown. Here we show that cytokines released by endothelial cells (ECs) contribute to long-COVID-associated cardiac dysfunction. Using thrombotic vascular tissues from patients with long COVID and induced pluripotent stem cell-derived ECs (iPSC-ECs), we modeled endotheliitis and observed similar dysfunction and cytokine upregulation, notably CCL2. Cardiac organoids comprising iPSC-ECs and iPSC-derived cardiomyocytes showed cardiac dysfunction after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exposure, driven by CCL2. Profiling of chromatin accessibility and gene expression at a single-cell resolution linked CCL2 to 'phenotype switching' and cardiac dysfunction, validated by high-throughput proteomics. Disease modeling of cardiac organoids and exposure of human ACE2 transgenic mice to SARS-CoV-2 spike proteins revealed that CCL2-induced oxidative stress promoted post-translational modification of cardiac proteins, leading to cardiac dysfunction. These findings suggest that EC-released cytokines contribute to cardiac dysfunction in long COVID, highlighting the importance of early vascular health monitoring in patients with long COVID.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s), under exclusive licence to Springer Nature Limited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Thomas</LastName><ForeName>Dilip</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0001-7427-5523</Identifier><AffiliationInfo><Affiliation>Stanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Noishiki</LastName><ForeName>Chikage</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Stanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Vascular Surgery, Department of Surgery, Stanford University School of Medicine, Stanford, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Gaddam</LastName><ForeName>Sadhana</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Dermatology, Stanford University School of Medicine, Stanford, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>David</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-1193-8307</Identifier><AffiliationInfo><Affiliation>Stanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Vascular Surgery, Department of Surgery, Stanford University School of Medicine, Stanford, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manhas</LastName><ForeName>Amit</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-6044-4576</Identifier><AffiliationInfo><Affiliation>Stanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Yu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Stanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tripathi</LastName><ForeName>Dipti</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Stanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Vascular Surgery, Department of Surgery, Stanford University School of Medicine, Stanford, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Baszucki Family Vascular Surgery Biobank, Stanford University School of Medicine, Stanford, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kathale</LastName><ForeName>Nimish</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adkar</LastName><ForeName>Shaunak S</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>Division of Vascular Surgery, Department of Surgery, Stanford University School of Medicine, Stanford, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Baszucki Family Vascular Surgery Biobank, Stanford University School of Medicine, Stanford, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garhyan</LastName><ForeName>Jaishree</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>In Vitro Biosafety Level 3 (BSL3) Service Center, Stanford University School of Medicine, Stanford, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Chun</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Departments of Physiology and Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Baohui</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-2857-7464</Identifier><AffiliationInfo><Affiliation>Division of Vascular Surgery, Department of Surgery, Stanford University School of Medicine, Stanford, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ross</LastName><ForeName>Elsie G</ForeName><Initials>EG</Initials><AffiliationInfo><Affiliation>Division of Vascular and Endovascular Surgery, Department of Surgery, University of California, San Diego, San Diego, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dalman</LastName><ForeName>Ronald L</ForeName><Initials>RL</Initials><AffiliationInfo><Affiliation>Stanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Vascular Surgery, Department of Surgery, Stanford University School of Medicine, Stanford, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Kevin C</ForeName><Initials>KC</Initials><AffiliationInfo><Affiliation>Department of Dermatology, Stanford University School of Medicine, Stanford, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oro</LastName><ForeName>Anthony E</ForeName><Initials>AE</Initials><AffiliationInfo><Affiliation>Department of Dermatology, Stanford University School of Medicine, Stanford, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sallam</LastName><ForeName>Karim</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Stanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Jason T</ForeName><Initials>JT</Initials><AffiliationInfo><Affiliation>Division of Vascular Surgery, Department of Surgery, Stanford University School of Medicine, Stanford, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Baszucki Family Vascular Surgery Biobank, Stanford University School of Medicine, Stanford, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Joseph C</ForeName><Initials>JC</Initials><Identifier Source="ORCID">0000-0002-6068-8041</Identifier><AffiliationInfo><Affiliation>Stanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Greenstone Biosciences, Palo Alto, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sayed</LastName><ForeName>Nazish</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-8229-721X</Identifier><AffiliationInfo><Affiliation>Stanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA, USA. sayedns@stanford.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA. sayedns@stanford.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Vascular Surgery, Department of Surgery, Stanford University School of Medicine, Stanford, CA, USA. sayedns@stanford.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Baszucki Family Vascular Surgery Biobank, Stanford University School of Medicine, Stanford, CA, USA. sayedns@stanford.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 HL161002</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K01 HL135455</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K99 HL163443-01</GrantID><Agency>U.S. Department of Health &amp; Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI)</Agency><Country/></Grant><Grant><GrantID>869015</GrantID><Agency>American Heart Association (American Heart Association, Inc.)</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Cardiovasc Res</MedlineTA><NlmUniqueID>9918284280206676</NlmUniqueID><ISSNLinking>2731-0590</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 3.4.17.23</RegistryNumber><NameOfSubstance UI="D000085962">Angiotensin-Converting Enzyme 2</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018932">Chemokine CCL2</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.17.23</RegistryNumber><NameOfSubstance UI="C000705307">ACE2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C111835">CCL2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D064370">Spike Glycoprotein, Coronavirus</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000657845">spike protein, SARS-CoV-2</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000085962" MajorTopicYN="Y">Angiotensin-Converting Enzyme 2</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018932" MajorTopicYN="Y">Chemokine CCL2</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D042783" MajorTopicYN="Y">Endothelial Cells</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057026" MajorTopicYN="N">Induced Pluripotent Stem Cells</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D032383" MajorTopicYN="N">Myocytes, Cardiac</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009940" MajorTopicYN="N">Organoids</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D064370" MajorTopicYN="N">Spike Glycoprotein, Coronavirus</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006331" MajorTopicYN="N">Heart Diseases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>15</Day><Hour>0</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>15</Day><Hour>0</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>14</Day><Hour>23</Hour><Minute>30</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39402206</ArticleId><ArticleId IdType="doi">10.1038/s44161-024-00543-8</ArticleId><ArticleId IdType="pii">10.1038/s44161-024-00543-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zhou, P. et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579, 270&#x2013;273 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32015507</ArticleId><ArticleId IdType="doi">10.1038/s41586-020-2012-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi, S. et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. 5, 802&#x2013;810 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32211816</ArticleId><ArticleId IdType="doi">10.1001/jamacardio.2020.0950</ArticleId></ArticleIdList></Reference><Reference><Citation>Teuwen, L.-A., Geldhof, V., Pasut, A. &amp; Carmeliet, P. COVID-19: the vasculature unleashed. Nat. Rev. Immunol. 20, 389&#x2013;391 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32439870</ArticleId><ArticleId IdType="doi">10.1038/s41577-020-0343-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly, Z., Xie, Y. &amp; Bowe, B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature 594, 259&#x2013;264 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33887749</ArticleId><ArticleId IdType="doi">10.1038/s41586-021-03553-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie, Y., Xu, E., Bowe, B. &amp; Al-Aly, Z. Long-term cardiovascular outcomes of COVID-19. Nat. Med. 28, 583&#x2013;590 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35132265</ArticleId><ArticleId IdType="doi">10.1038/s41591-022-01689-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Oikonomou, E. et al. Endothelial dysfunction in acute and long standing COVID-19: a prospective cohort study. Vascul. Pharmacol. 144, 106975 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35248780</ArticleId><ArticleId IdType="doi">10.1016/j.vph.2022.106975</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon, A. C. et al. Interleukin-6 receptor antagonists in critically ill patients with Covid-19. N. Engl. J. Med. 384, 1491&#x2013;1502 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33631065</ArticleId><ArticleId IdType="doi">10.1056/NEJMoa2100433</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan, R. et al. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science 367, 1444&#x2013;1448 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32132184</ArticleId><ArticleId IdType="doi">10.1126/science.abb2762</ArticleId></ArticleIdList></Reference><Reference><Citation>Varga, Z. et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet 395, 1417&#x2013;1418 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32325026</ArticleId><ArticleId IdType="doi">10.1016/S0140-6736(20)30937-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma, Z. et al. A human pluripotent stem cell-based model of SARS-CoV-2 infection reveals an ACE2-independent inflammatory activation of vascular endothelial cells through TLR4. Stem Cell Rep. 17, 538&#x2013;555 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2022.01.015</ArticleId></ArticleIdList></Reference><Reference><Citation>McCracken, I. R. et al. Lack of evidence of angiotensin-converting enzyme 2 expression and replicative infection by SARS-CoV-2 in human endothelial cells. Circulation 143, 865&#x2013;868 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33405941</ArticleId><ArticleId IdType="pmc">7899720</ArticleId><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.052824</ArticleId></ArticleIdList></Reference><Reference><Citation>Lui, K. O., Ma, Z. &amp; Dimmeler, S. SARS-CoV-2 induced vascular endothelial dysfunction: direct or indirect effects? Cardiovas. Res. 120, 34&#x2013;43 (2023).</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvad191</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, F. et al. SARS-CoV-2 pseudovirus infectivity and expression of viral entry-related factors ACE2, TMPRSS2, Kim-1 and NRP-1 in human cells from the respiratory, urinary, digestive, reproductive and immune systems. J. Med. Virol. 93, 6671&#x2013;6685 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34324210</ArticleId><ArticleId IdType="pmc">8426707</ArticleId><ArticleId IdType="doi">10.1002/jmv.27244</ArticleId></ArticleIdList></Reference><Reference><Citation>Monteil, V. et al. Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2. Cell 181, 905&#x2013;913 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32333836</ArticleId><ArticleId IdType="pmc">7181998</ArticleId><ArticleId IdType="doi">10.1016/j.cell.2020.04.004</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang, L. et al. A human pluripotent stem cell-based platform to study SARS-CoV-2 tropism and model virus infection in human cells and organoids. Cell Stem Cell 27, 125&#x2013;136 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32579880</ArticleId><ArticleId IdType="pmc">7303620</ArticleId><ArticleId IdType="doi">10.1016/j.stem.2020.06.015</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei, Y. et al. SARS-CoV-2 spike protein impairs endothelial function via downregulation of ACE 2. Circ. Res. 128, 1323&#x2013;1326 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33784827</ArticleId><ArticleId IdType="pmc">8091897</ArticleId><ArticleId IdType="doi">10.1161/CIRCRESAHA.121.318902</ArticleId></ArticleIdList></Reference><Reference><Citation>Stahl, K. et al. Injury to the endothelial glycocalyx in critically ill patients with COVID-19. Am. J. Respir. Crit. Care Med. 202, 1178&#x2013;1181 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32833500</ArticleId><ArticleId IdType="pmc">7560808</ArticleId><ArticleId IdType="doi">10.1164/rccm.202007-2676LE</ArticleId></ArticleIdList></Reference><Reference><Citation>Wichmann, D. et al. Autopsy findings and venous thromboembolism in patients with COVID-19: a prospective cohort study. Ann. Intern. Med. 173, 268&#x2013;277 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32374815</ArticleId><ArticleId IdType="doi">10.7326/M20-2003</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellosta, R. et al. Acute limb ischemia in patients with COVID-19 pneumonia. J. Vasc. Surg. 72, 1864&#x2013;1872 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32360679</ArticleId><ArticleId IdType="pmc">7188654</ArticleId><ArticleId IdType="doi">10.1016/j.jvs.2020.04.483</ArticleId></ArticleIdList></Reference><Reference><Citation>Massion, P. B. &amp; Balligand, J. L. Modulation of cardiac contraction, relaxation and rate by the endothelial nitric oxide synthase (eNOS): lessons from genetically modified mice. J. Physiol. 546, 63&#x2013;75 (2003).</Citation><ArticleIdList><ArticleId IdType="pubmed">12509479</ArticleId><ArticleId IdType="doi">10.1113/jphysiol.2002.025973</ArticleId></ArticleIdList></Reference><Reference><Citation>Nuzzi, V. et al. Impaired right ventricular longitudinal strain without pulmonary hypertension in patients who have recovered from COVID-19. Circ. Cardiovasc. Imaging 14, e012166 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33827250</ArticleId><ArticleId IdType="doi">10.1161/CIRCIMAGING.120.012166</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang, C. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395, 497&#x2013;506 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">31986264</ArticleId><ArticleId IdType="pmc">7159299</ArticleId><ArticleId IdType="doi">10.1016/S0140-6736(20)30183-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan, W.-J. et al. Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med. 382, 1708&#x2013;1720 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32109013</ArticleId><ArticleId IdType="doi">10.1056/NEJMoa2002032</ArticleId></ArticleIdList></Reference><Reference><Citation>Shafi, A. M. A., Shaikh, S. A., Shirke, M. M., Iddawela, S. &amp; Harky, A. Cardiac manifestations in COVID-19 patients&#x2014;a systematic review. J. Card. Surg. 35, 1988&#x2013;2008 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32652713</ArticleId><ArticleId IdType="pmc">7404674</ArticleId><ArticleId IdType="doi">10.1111/jocs.14808</ArticleId></ArticleIdList></Reference><Reference><Citation>Naneishvili, T., Khalil, A., O&#x2019;Leary, R. &amp; Prasad, N. Fulminant myocarditis as an early presentation of SARS-CoV-2. BMJ Case Rep. 13, e237553 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32928810</ArticleId><ArticleId IdType="pmc">7490957</ArticleId><ArticleId IdType="doi">10.1136/bcr-2020-237553</ArticleId></ArticleIdList></Reference><Reference><Citation>Bikdeli, B. et al. COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy and follow-up: JACC state-of-the-art review. J. Am. Coll. Cardiol. 75, 2950&#x2013;2973 (2020).</Citation></Reference><Reference><Citation>Li, Y. et al. Single-cell transcriptome analysis reveals dynamic cell populations and differential gene expression patterns in control and aneurysmal human aortic tissue. Circulation 142, 1374&#x2013;1388 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">33017217</ArticleId><ArticleId IdType="pmc">7539140</ArticleId><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.046528</ArticleId></ArticleIdList></Reference><Reference><Citation>Dawson, A. et al. Single-cell analysis of aneurysmal aortic tissue in patients with Marfan syndrome reveals dysfunctional TGF-&#x3b2; signaling. Genes (Basel) 13, 95 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/genes13010095</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Flanagan, C. H. et al. Dissociation of solid tumor tissues with cold active protease for single-cell RNA-seq minimizes conserved collagenase-associated stress responses. Genome Biol. 20, 210 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31623682</ArticleId><ArticleId IdType="pmc">6796327</ArticleId><ArticleId IdType="doi">10.1186/s13059-019-1830-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Michalik, K. M. et al. Long noncoding RNA MALAT1 regulates endothelial cell function and vessel growth. Circ. Res. 114, 1389&#x2013;1397 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">24602777</ArticleId><ArticleId IdType="doi">10.1161/CIRCRESAHA.114.303265</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed, A. S. I. et al. Long noncoding RNA NEAT1 (nuclear paraspeckle assembly transcript 1) is critical for phenotypic switching of vascular smooth muscle cells. Proc. Natl Acad. Sci. USA 115, E8660&#x2013;E8667 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">30139920</ArticleId><ArticleId IdType="doi">10.1073/pnas.1803725115</ArticleId></ArticleIdList></Reference><Reference><Citation>Deshmane, S. L., Kremlev, S., Amini, S. &amp; Sawaya, B. E. Monocyte chemoattractant protein-1 (MCP-1): an overview. J. Interferon Cytokine Res. 29, 313&#x2013;326 (2009).</Citation><ArticleIdList><ArticleId IdType="pubmed">19441883</ArticleId><ArticleId IdType="doi">10.1089/jir.2008.0027</ArticleId></ArticleIdList></Reference><Reference><Citation>Sayed, N., Liu, C. &amp; Wu, J. C. Translation of human-induced pluripotent stem cells: from clinical trial in a dish to precision medicine. J. Am. Coll. Cardiol. 67, 2161&#x2013;2176 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27151349</ArticleId><ArticleId IdType="doi">10.1016/j.jacc.2016.01.083</ArticleId></ArticleIdList></Reference><Reference><Citation>Sayed, N. et al. Clinical trial in a dish using iPSCs shows lovastatin improves endothelial dysfunction and cellular cross-talk in LMNA cardiomyopathy. Sci. Transl. Med. 12, eaax9276 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32727917</ArticleId><ArticleId IdType="pmc">7557117</ArticleId><ArticleId IdType="doi">10.1126/scitranslmed.aax9276</ArticleId></ArticleIdList></Reference><Reference><Citation>Sayed, N. et al. Transdifferentiation of human fibroblasts to endothelial cells: role of innate immunity. Circulation 131, 300&#x2013;309 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25359165</ArticleId><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.113.007394</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma, A. et al. High-throughput screening of tyrosine kinase inhibitor cardiotoxicity with human induced pluripotent stem cells. Sci. Transl. Med. 9, eaaf2584 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28202772</ArticleId><ArticleId IdType="pmc">5409837</ArticleId><ArticleId IdType="doi">10.1126/scitranslmed.aaf2584</ArticleId></ArticleIdList></Reference><Reference><Citation>Montezano, A. C. et al. SARS-CoV-2 spike protein induces endothelial inflammation via ACE2 independently of viral replication. Sci. Rep. 13, 14086 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37640791</ArticleId><ArticleId IdType="pmc">10462711</ArticleId><ArticleId IdType="doi">10.1038/s41598-023-41115-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas, D., de Jesus Perez, V. A. &amp; Sayed, N. An evidence appraisal of heart organoids in a dish and commensurability to human heart development in vivo. BMC Cardiovasc. Disord. 22, 122 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35317745</ArticleId><ArticleId IdType="pmc">8939187</ArticleId><ArticleId IdType="doi">10.1186/s12872-022-02543-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas, D., Kim, H., Lopez, N. &amp; Wu, J.C. Fabrication of 3D cardiac microtissue arrays using human iPSC-derived cardiomyocytes, cardiac fibroblasts and endothelial cells. J. Vis. Exp. https://doi.org/10.3791/61879 (2021).</Citation></Reference><Reference><Citation>Liu, C., Oikonomopoulos, A., Sayed, N. &amp; Wu, J. C. Modeling human diseases with induced pluripotent stem cells: from 2D to 3D and beyond. Development 145, dev156166 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29519889</ArticleId><ArticleId IdType="pmc">5868991</ArticleId><ArticleId IdType="doi">10.1242/dev.156166</ArticleId></ArticleIdList></Reference><Reference><Citation>Sallam, K. et al. Modeling effects of immunosuppressive drugs on human hearts using induced pluripotent stem cell-derived cardiac organoids and single-cell RNA sequencing. Circulation 145, 1367&#x2013;1369 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35467958</ArticleId><ArticleId IdType="pmc">9472526</ArticleId><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.121.054317</ArticleId></ArticleIdList></Reference><Reference><Citation>Dridi, H. et al. Intracellular calcium leak in heart failure and atrial fibrillation: a unifying mechanism and therapeutic target. Nat. Rev. Cardiol. 17, 732&#x2013;747 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32555383</ArticleId><ArticleId IdType="pmc">8362847</ArticleId><ArticleId IdType="doi">10.1038/s41569-020-0394-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Paludan, S. R. &amp; Mogensen, T. H. Innate immunological pathways in COVID-19 pathogenesis. Science Immunol. 7, eabm5505 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abm5505</ArticleId></ArticleIdList></Reference><Reference><Citation>Valiente-Alandi, I. et al. Inhibiting fibronectin attenuates fibrosis and improves cardiac function in a model of heart failure. Circulation 138, 1236&#x2013;1252 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29653926</ArticleId><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.118.034609</ArticleId></ArticleIdList></Reference><Reference><Citation>Reinecke, H. et al. Lack of thrombospondin-2 reduces fibrosis and increases vascularity around cardiac cell grafts. Cardiovasc. Pathol. 22, 91&#x2013;95 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">22512900</ArticleId><ArticleId IdType="doi">10.1016/j.carpath.2012.03.005</ArticleId></ArticleIdList></Reference><Reference><Citation>Han, Y. et al. SARS-CoV-2 infection induces ferroptosis of sinoatrial node pacemaker cells. Circ. Res. 130, 963&#x2013;977 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35255712</ArticleId><ArticleId IdType="doi">10.1161/CIRCRESAHA.121.320518</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu, H. et al. Postmortem high-dimensional immune profiling of severe COVID-19 patients reveals distinct patterns of immunosuppression and immunoactivation. Nat. Commun. 13, 269 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35022412</ArticleId><ArticleId IdType="doi">10.1038/s41467-021-27723-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Sayed, N. et al. An inflammatory aging clock (iAge) based on deep learning tracks multimorbidity, immunosenescence, frailty and cardiovascular aging. Nat. Aging 1, 598&#x2013;615 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34888528</ArticleId><ArticleId IdType="doi">10.1038/s43587-021-00082-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Evrard, S. M. et al. Endothelial to mesenchymal transition is common in atherosclerotic lesions and is associated with plaque instability. Nat. Commun. 7, 11853 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27340017</ArticleId><ArticleId IdType="doi">10.1038/ncomms11853</ArticleId></ArticleIdList></Reference><Reference><Citation>Chernyak, B. V. et al. COVID-19 and oxidative stress. Biochemistry (Mosc.) 85, 1543&#x2013;1553 (2020).</Citation></Reference><Reference><Citation>Tomin, T., Schittmayer, M., Honeder, S., Heininger, C. &amp; Birner-Gruenberger, R. Irreversible oxidative post-translational modifications in heart disease. Expert Rev. Proteomics 16, 681&#x2013;693 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31361162</ArticleId><ArticleId IdType="pmc">6816499</ArticleId><ArticleId IdType="doi">10.1080/14789450.2019.1645602</ArticleId></ArticleIdList></Reference><Reference><Citation>Wehrens, X. H. T. et al. FKBP12.6 deficiency and defective calcium release channel (ryanodine receptor) function linked to exercise-induced sudden cardiac death. Cell 113, 829&#x2013;840 (2003).</Citation><ArticleIdList><ArticleId IdType="pubmed">12837242</ArticleId><ArticleId IdType="doi">10.1016/S0092-8674(03)00434-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Wehrens, X. H. T. et al. Protection from cardiac arrhythmia through ryanodine receptor-stabilizing protein calstabin2. Science 304, 292&#x2013;296 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">15073377</ArticleId><ArticleId IdType="doi">10.1126/science.1094301</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng, J. et al. COVID-19 treatments and pathogenesis including anosmia in K18-hACE2 mice. Nature 589, 603&#x2013;607 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33166988</ArticleId><ArticleId IdType="doi">10.1038/s41586-020-2943-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Oladunni, F. S. et al. Lethality of SARS-CoV-2 infection in K18 human angiotensin-converting enzyme 2 transgenic mice. Nat. Commun. 11, 6122 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">33257679</ArticleId><ArticleId IdType="pmc">7705712</ArticleId><ArticleId IdType="doi">10.1038/s41467-020-19891-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Golden, J. W. et al. Human angiotensin-converting enzyme 2 transgenic mice infected with SARS-CoV-2 develop severe and fatal respiratory disease. JCI Insight 5, e142032 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32841215</ArticleId><ArticleId IdType="pmc">7566707</ArticleId><ArticleId IdType="doi">10.1172/jci.insight.142032</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown, K., Yahyouche, A., Haroon, S., Camaradou, J. &amp; Turner, G. Long COVID and self-management. Lancet 399, 355 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35065779</ArticleId><ArticleId IdType="pmc">8776283</ArticleId><ArticleId IdType="doi">10.1016/S0140-6736(21)02798-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Abou-Ismail, M. Y., Diamond, A., Kapoor, S., Arafah, Y. &amp; Nayak, L. The hypercoagulable state in COVID-19: incidence, pathophysiology and management. Thromb. Res. 194, 101&#x2013;115 (2020).</Citation></Reference><Reference><Citation>Liu, C. et al. Statins improve endothelial function via suppression of epigenetic-driven EndMT. Nat. Cardiovasc. Res. 2, 467&#x2013;485 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37693816</ArticleId><ArticleId IdType="pmc">10489108</ArticleId><ArticleId IdType="doi">10.1038/s44161-023-00267-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Maccio, U. et al. SARS-CoV-2 leads to a small vessel endotheliitis in the heart. EBioMedicine 63, 103182 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33422990</ArticleId><ArticleId IdType="pmc">7808909</ArticleId><ArticleId IdType="doi">10.1016/j.ebiom.2020.103182</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang, L. et al. An immuno-cardiac model for macrophage-mediated inflammation in COVID-19 hearts. Circ. Res. 129, 33&#x2013;46 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33853355</ArticleId><ArticleId IdType="pmc">8225586</ArticleId><ArticleId IdType="doi">10.1161/CIRCRESAHA.121.319060</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, S. et al. Metabolic reprogramming and epigenetic changes of vital organs in SARS-CoV-2-induced systemic toxicity. JCI Insight 6, e145027 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33284134</ArticleId><ArticleId IdType="pmc">7934846</ArticleId><ArticleId IdType="doi">10.1172/jci.insight.145027</ArticleId></ArticleIdList></Reference><Reference><Citation>Grune, J. et al. Virus-induced acute respiratory distress syndrome causes cardiomyopathy through eliciting inflammatory responses in the heart. Circulation 150, 49&#x2013;61 (2024).</Citation><ArticleIdList><ArticleId IdType="pubmed">38506045</ArticleId><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.123.066433</ArticleId></ArticleIdList></Reference><Reference><Citation>Georgakis, M. K., Bernhagen, J., Heitman, L. H., Weber, C. &amp; Dichgans, M. Targeting the CCL2&#x2013;CCR2 axis for atheroprotection. Eur. Heart J. 43, 1799&#x2013;1808 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35567558</ArticleId><ArticleId IdType="doi">10.1093/eurheartj/ehac094</ArticleId></ArticleIdList></Reference><Reference><Citation>Khyzha, N. et al. Regulation of CCL2 expression in human vascular endothelial cells by a neighboring divergently transcribed long noncoding RNA. Proc. Natl Acad. Sci. USA 116, 16410&#x2013;16419 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31350345</ArticleId><ArticleId IdType="pmc">6697820</ArticleId><ArticleId IdType="doi">10.1073/pnas.1904108116</ArticleId></ArticleIdList></Reference><Reference><Citation>Frangogiannis, N. G. Chemokines in the ischemic myocardium: from inflammation to fibrosis. Inflamm. Res. 53, 585&#x2013;595 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">15693606</ArticleId><ArticleId IdType="doi">10.1007/s00011-004-1298-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore, J. B. &amp; June, C. H. Cytokine release syndrome in severe COVID-19. Science 368, 473&#x2013;474 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32303591</ArticleId><ArticleId IdType="doi">10.1126/science.abb8925</ArticleId></ArticleIdList></Reference><Reference><Citation>Kyriazopoulou, E. et al. Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial. Nat. Med. 27, 1752&#x2013;1760 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34480127</ArticleId><ArticleId IdType="pmc">8516650</ArticleId><ArticleId IdType="doi">10.1038/s41591-021-01499-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as, C., Palacios-Ce&#xf1;a, D., G&#xf3;mez-Mayordomo, V., Cuadrado, M. L. &amp; Florencio, L. L. Defining post-COVID symptoms (post-acute COVID, long COVID, persistent post-COVID): an integrative classification. Int. J. Environ. Res. Public Health 18, 2621 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33807869</ArticleId><ArticleId IdType="pmc">7967389</ArticleId><ArticleId IdType="doi">10.3390/ijerph18052621</ArticleId></ArticleIdList></Reference><Reference><Citation>Deer, R. R. et al. Characterizing long COVID: deep phenotype of a complex condition. eBioMedicine 74, 103722 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34839263</ArticleId><ArticleId IdType="doi">10.1016/j.ebiom.2021.103722</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizrahi, B. et al. Long covid outcomes at one year after mild SARS-CoV-2 infection: nationwide cohort study. BMJ 380, e072529 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36631153</ArticleId><ArticleId IdType="doi">10.1136/bmj-2022-072529</ArticleId></ArticleIdList></Reference><Reference><Citation>Khanamiri, S. et al. Marked vascular dysfunction in a case of peripartum cardiomyopathy. J. Vasc. Res. 56, 11&#x2013;15 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30763932</ArticleId><ArticleId IdType="doi">10.1159/000496163</ArticleId></ArticleIdList></Reference><Reference><Citation>Huebsch, N. et al. Automated video-based analysis of contractility and calcium flux in human-induced pluripotent stem cell-derived cardiomyocytes cultured over different spatial scales. Tissue Eng. Part C Methods 21, 467&#x2013;479 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25333967</ArticleId><ArticleId IdType="doi">10.1089/ten.tec.2014.0283</ArticleId></ArticleIdList></Reference><Reference><Citation>Greensmith, D. J. Ca analysis: an Excel based program for the analysis of intracellular calcium transients including multiple, simultaneous regression analysis. Comput. Methods Programs Biomed. 113, 241&#x2013;250 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">24125908</ArticleId><ArticleId IdType="doi">10.1016/j.cmpb.2013.09.004</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu, C. et al. HIF1&#x3b1; regulates early metabolic changes due to activation of innate immunity in nuclear reprogramming. Stem Cell Rep. 14, 192&#x2013;200 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2020.01.006</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>